SLC5A2 and diabetic kidney disease: Furthermore, SGLT2 inhibitors impact kidney function by regulating cell migration, reducing oxidative stress, and mitigating the effects of high glucose levels on the proximal tubule cells, demonstrating high potential as therapeutic agents for diabetic nephropathy [231].